Parametric Portfolio Associates’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.04M | Buy |
334,713
+95,698
| +40% | +$298K | ﹤0.01% | 2766 |
|
|
2021
Q4 | $808K | Buy |
239,015
+2,258
| +1% | +$7.63K | ﹤0.01% | 2867 |
|
|
2021
Q3 | $864K | Buy |
236,757
+21,817
| +10% | +$79.6K | ﹤0.01% | 2865 |
|
|
2021
Q2 | $937K | Sell |
214,940
-88,939
| -29% | -$388K | ﹤0.01% | 2795 |
|
|
2021
Q1 | $1.38M | Sell |
303,879
-240,146
| -44% | -$1.09M | ﹤0.01% | 2997 |
|
|
2020
Q4 | $3.12M | Sell |
544,025
-7,233
| -1% | -$41.5K | ﹤0.01% | 2384 |
|
|
2020
Q3 | $3.99M | Sell |
551,258
-25,460
| -4% | -$184K | ﹤0.01% | 2050 |
|
|
2020
Q2 | $2.01M | Buy |
576,718
+404,078
| +234% | +$1.41M | ﹤0.01% | 2501 |
|
|
2020
Q1 | $256K | Buy |
172,640
+57,663
| +50% | +$85.5K | ﹤0.01% | 3446 |
|
|
2019
Q4 | $225K | Sell |
114,977
-66,543
| -37% | -$130K | ﹤0.01% | 3699 |
|
|
2019
Q3 | $929K | Buy |
181,520
+151,682
| +508% | +$776K | ﹤0.01% | 3064 |
|
|
2019
Q2 | $214K | Buy |
29,838
+4,920
| +20% | +$35.3K | ﹤0.01% | 3721 |
|
|
2019
Q1 | $331K | Buy |
24,918
+9,316
| +60% | +$124K | ﹤0.01% | 3515 |
|
|
2018
Q4 | $123K | Buy |
+15,602
| New | +$123K | ﹤0.01% | 3759 |
|
|
2018
Q2 | – | Sell |
-122,984
| Closed | -$1.6M | – | 3952 |
|
|
2018
Q1 | $1.6M | Sell |
122,984
-14,099
| -10% | -$183K | ﹤0.01% | 2759 |
|
|
2017
Q4 | $1.26M | Sell |
137,083
-7,822
| -5% | -$72K | ﹤0.01% | 2892 |
|
|
2017
Q3 | $1.17M | Buy |
+144,905
| New | +$1.17M | ﹤0.01% | 2943 |
|